ISABELLE DSOUZA: Open Payments
NPI 1649991084 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,661 in 90 payments from 15 companies in 2025. Trend: 2023 $513 · 2024 $992 · 2025 $1,661
Food & beverage: $1,661
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $285 |
| Corium, LLC | 8 | $217 |
| Otsuka America Pharmaceutical, Inc. | 13 | $211 |
| Teva Pharmaceuticals USA, Inc. | 9 | $192 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $125 |
| Noven Therapeutics, LLC | 6 | $112 |
| Janssen Pharmaceuticals, Inc | 5 | $96 |
| Lundbeck LLC | 4 | $75 |
| Vanda Pharmaceuticals Inc. | 3 | $68 |
| Neurocrine BioSciences, Inc. | 2 | $68 |
Products named: VRAYLAR, REXULTI, Azstarys, AUSTEDO XR, CAPLYTA, Xelstrym, SPRAVATO, FANAPT.
Industry payments across TX — which companies pay providers there.
